|34.84||+0.02 / +0.06%|
Data as of 3:59pm ET
|34.84||0.00 / 0.00%|
The 5 analysts offering 12-month price forecasts for KYTHERA Biopharmaceuticals Inc have a median target of 56.00, with a high estimate of 68.00 and a low estimate of 41.00. The median estimate represents a +60.73% increase from the last price of 34.84.
The current consensus among 5 polled investment analysts is to Buy stock in KYTHERA Biopharmaceuticals Inc. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.